MSD in talks with 5 Indian drugmakers for clinical trial of COVID drug Molnupiravir Medical Dialogues Team30 Jun 2021 5:28 PM ISTNew Delhi: MSD Pharmaceuticals, the wholly owned subsidiary of Merck Sharp Dohme, known as Merck & Co in the US, announced that it has decided to...
Suven Pharma, CSIR-IICT, NIIST collaborate for COVID drug Molnupiravir Ruchika Sharma11 Jun 2021 11:00 AM ISTAccording to a study published in the journal "Nature Microbiology," the drug can completely suppress the COVID virus transmission within 24 hours,...
DCGI nod to Optimus Pharma Molnupiravir Phase 3 trials on COVID patients Ruchika Sharma20 May 2021 2:00 PM ISTHyderabad: Drugs Manufacturer from Hyderabad, Optimus Pharma on Wednesday said it has received Drugs Controller General of India (DCGI) nod for...
Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir Medical Dialogues Team28 April 2021 11:51 AM ISTMumbai: In order to accelerate and expand global access to Molnupiravir for treating Covid-19, Merck (known as MSD Pharmaceuticals outside the United...
Merck halts 2 Covid-19 vaccines development due to weak immune response MD Bureau26 Jan 2021 2:34 PM ISTWashington: US pharmaceutical giant Merck & Co announced that it is discontinuing development of its Covid-19 vaccine candidates -- V590 and...
COVID-19: Antiviral drug Molnupiravir blocks virus transmission within 24 hours, claims Study Ruchika Sharma7 Dec 2020 4:30 PM IST"This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission. MK-4482/EIDD-2801 could be game-changing," said...
